Detalhe da pesquisa
1.
SGLT2 inhibitors improve plasma atherogenic biomarkers in patients with type 2 diabetes: a real-world retrospective observational study.
Minerva Endocrinol (Torino)
; 48(3): 295-304, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-33979071
2.
Hyperandrogenism-related metabolic changes in drug-naïve transmen compared to cisgender women: a case-controlled study.
Endokrynol Pol
; 2023 Aug 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37577993
3.
Vitamin D receptor and estrogen receptor gene polymorphisms in men with type 2 diabetes: Effects on Bone Metabolism.
J Diabetes Metab Disord
; 21(2): 1293-1299, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36404811
4.
When do we need to suspect maturity onset diabetes of the young in patients with type 2 diabetes mellitus?
Arch Endocrinol Metab
; 66(1): 32-39, 2022 Mar 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35029855
5.
Genetic and Clinical Characterization of Patients with Maturity-Onset of Diabetes of the Young (MODY): Identification of Novel Variations.
Balkan Med J
; 38(5): 272-277, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34462253
6.
When do we need to suspect maturity onset diabetes of the young in patients with type 2 diabetes mellitus?
Arch. endocrinol. metab. (Online)
; 66(1): 32-39, Jan.-Feb. 2022. tab
Artigo
em Inglês
| LILACS | ID: biblio-1364313